BAM
DCPH

Blueshift Asset Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Blueshift Asset Management’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-16,798
Closed -$615K – 1354
2021
Q2 		$615K Buy
16,798
+11,289
+205% +$437K 0.03% 502
2021
Q1 		$247K Sell
5,509
-2,203
-29% -$103K 0.03% 705
2020
Q4 		$440K Buy
+7,712
New +$457K 0.05% 439

Other funds holding DCPH

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Blueshift Asset Management's DCPH Position: Q3 2021 in Review

Blueshift Asset Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q3 2021, closing a stake of 16,798 shares — an estimated $615K sold.

Blueshift Asset Management first reported a position in DCPH in Q4 2020 and held it in 3 quarters. The position peaked at $615K in Q2 2021. 161 funds tracked by Wall St. Rank hold DCPH as of Q3 2021.

  • Blueshift Asset Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Blueshift Asset Management sold 16,798 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q3 2021, an estimated $615K.
  • Blueshift Asset Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2020 and held it in 3 quarters.
  • Blueshift Asset Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $615K in Q2 2021.
  • 161 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q3 2021.

Based on Blueshift Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.